Rare and Atypical Diabetes Network
RARE and Atypical Diabetes Network(RADIANT)
This network gathers genetic, blood, and clinical data from people with uncommon or unclear forms of diabetes to find underlying causes and improve care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11309213 on NIH RePORTER |
What this research studies
If your diabetes does not fit typical Type 1 or Type 2 labels, this network invites you to share your medical history, family information, and blood samples. The team performs whole genome sequencing, RNA sequencing, and detailed blood metabolite testing, and creates patient-specific stem cell models to study how your cells function. They also enroll informative family members and carry out in-depth clinical testing to match symptoms with biological findings. Together these steps aim to define new forms of diabetes and point toward more tailored treatments for people like you.
Who could benefit from this research
Good fit: Adults with diabetes that is unusual or doesn't clearly fit Type 1 or Type 2 — for example suspected monogenic (MODY), ketosis-prone, brittle diabetes, or unclear antibody status — are ideal candidates.
Not a fit: People with straightforward, typical Type 1 or Type 2 diabetes without unusual clinical features are unlikely to receive direct benefit from this network.
Why it matters
Potential benefit: Could identify specific genetic or biological causes for an individual's diabetes, enabling more accurate diagnoses and personalized treatment options.
How similar studies have performed: Previous genetic and deep-phenotyping studies have successfully identified monogenic diabetes causes, though assembling many rare and atypical forms into a coordinated network is a newer effort.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Balasubramanyam, Ashok — Baylor College of Medicine
- Study coordinator: Balasubramanyam, Ashok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.